SEC Form 4 · accession 0001628280-16-010064
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Edward Machek
Officer — VP-Research & Development
Period of report
Jan 4, 2016
Accepted (ET)
Jan 4, 2016 · 2:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 4, 2016 | A | 1,797 | $0.00 | A | 33,900 | D | |
| Common StockF2 | Jan 4, 2016 | F | 676 | $10.01 | D | 33,224 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This award was originally reported on a Form 3 filed with the Securities and Exchange Commission on July 19, 2013. A related goal was achieved and shares vested.
- F2Withholding of shares to satisfy statutory tax withholding obligations related to the vested shares. The Reporting Person made a withholding election on January 4, 2016.